|
WDHD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.21499946057224E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.16800038927079E-10 |
| Normal-vs-Stage2 |
9.377300E-03 |
| Normal-vs-Stage3 |
7.78319999561461E-08 |
| Normal-vs-Stage4 |
2.019100E-04 |
| Stage1-vs-Stage2 |
4.514200E-02 |
| Stage1-vs-Stage3 |
7.999200E-01 |
| Stage1-vs-Stage4 |
4.588600E-01 |
| Stage2-vs-Stage3 |
5.032200E-02 |
| Stage2-vs-Stage4 |
2.652800E-01 |
| Stage3-vs-Stage4 |
4.081400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.28340005289829E-10 |
| Normal-vs-AfricanAmerican |
2.280000E-03 |
| Normal-vs-Asian |
3.11969999999828E-06 |
| Caucasian-vs-AfricanAmerican |
4.662000E-01 |
| Caucasian-vs-Asian |
7.268400E-01 |
| AfricanAmerican-vs-Asian |
6.987400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.30349999980662E-07 |
| Normal-vs-Female |
3.29700045043069E-10 |
| Male-vs-Female |
3.951000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.25260032848951E-10 |
| Normal-vs-Age(41-60Yrs) |
4.37069999970063E-07 |
| Normal-vs-Age(61-80Yrs) |
4.85699999996925E-06 |
| Normal-vs-Age(81-100Yrs) |
1.186610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.149800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.195380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.386000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.714800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.046600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.114800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.210400E-01 |
| Classical-VS-Follicular |
7.10540515314051E-11 |
| Classical-VS-Other |
3.418400E-01 |
| Classical-VS-Normal |
2.27939889185791E-12 |
| Tall-VS-Follicular |
7.61280000038944E-07 |
| Tall-VS-Other |
1.583570E-01 |
| Tall-VS-Normal |
5.41429999945109E-07 |
| Follicular-VS-Other |
2.387400E-01 |
| Follicular-VS-Normal |
3.011600E-01 |
| Other-VS-Normal |
5.712300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.4594999999178E-07 |
| Normal-vs-N1 |
7.63100000000794E-05 |
| N0-vs-N1 |
2.536000E-01 |
|
|
